Oxygenta Pharmaceutical Ltd.
BSE: 524636
₹50.23
₹0.48
(0.96%)
As on 08-Jun-2026IST
Market cap
₹186 Cr
Revenue (TTM)
₹113 Cr
P/E Ratio
--
P/B Ratio
-4.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-18 Cr
-
ROE
0 %
-
ROCE
-25.6 %
-
Industry P/E
45.14
-
EV/EBITDA
-19.4
-
Debt to Equity
-1.8
-
Book Value
₹-11.5
-
EPS
₹-4.8
-
Face value
10
-
Shares outstanding
36,983,500
10 Years Aggregate
CFO
₹-23.12 Cr
EBITDA
₹-44.15 Cr
Net Profit
₹-47.29 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Oxygenta Pharma
| -10.0 | -13.1 | -0.7 | -59.6 | 17.2 | -- | -- |
|
BSE Healthcare
| 7.8 | 0.9 | 7.5 | 8.3 | 24.2 | 13.6 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Oxygenta Pharma
| -34.9 | 173.3 | 9.9 | 2.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Oxygenta Pharma
|
50.2 | 185.8 | 112.9 | -17.6 | -15.7 | -- | -- | -4.4 |
| 3,316.2 | 27,112.9 | 1,339.4 | 356.4 | 33.2 | 23.2 | 76.1 | 16.4 | |
| 424.3 | 16,226.6 | 2,268.6 | 150.1 | 10.6 | 5.4 | 90.5 | 4.1 | |
| 766.4 | 19,006.0 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.9 | 3.7 | |
| 957.4 | 15,162.8 | 8,279.6 | 397.8 | 9.9 | 6.4 | 38 | 2.1 | |
| 868.3 | 15,557.5 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 11 | 1.7 | |
| 1,737.8 | 19,927.2 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.4 | |
| 165.3 | 22,020.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 449.5 | 18,132.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 57.3 | 3.7 | |
| 1,892.9 | 30,770.3 | 3,373.0 | 199.0 | 12.6 | 5.9 | 144.5 | 6.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Oxygenta Pharma
S.S. Organics Limited manufactures and sells anti ulcerative and anti-bacterial drugs in India. It is also involved in contract manufacturing work, including cirprofloxacin HCL from Q-acid and cloxacillim sodium. The company was incorporated in 1990... and is based in Hyderabad, India. Read more
-
Incorporated
1990
-
Chairman
--
-
Managing Director
--
-
Headquarters
Sangareddy, Telangana
-
Website
Looking for more details about Oxygenta Pharmaceutical Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Oxygenta Pharma
What is the current share price of Oxygenta Pharmaceutical Ltd Today?
The share price of Oxygenta Pharmaceutical Ltd is ₹50.23 (BSE) as of 08-Jun-2026 IST. Oxygenta Pharmaceutical Ltd has given a return of 17.24% in the last 3 years.
What is the current PB & PE ratio of Oxygenta Pharmaceutical Ltd?
Since, TTM earnings of Oxygenta Pharmaceutical Ltd is negative, P/E ratio is not available.
The P/B ratio of Oxygenta Pharmaceutical Ltd is -4.36 times as on 08-Jun-2026, a 212 discount to its peers’ median range of 3.90 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
-11.76
|
|
2024
|
0.00
|
-4.69
|
|
2023
|
0.00
|
-1.13
|
|
2022
|
0.00
|
-0.99
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Oxygenta Pharmaceutical Ltd?
The 52-week high and low of Oxygenta Pharmaceutical Ltd are Rs 133.50 and Rs 45.30 as of 09-Jun-2026.
What is the market cap of Oxygenta Pharmaceutical Ltd?
Oxygenta Pharmaceutical Ltd has a market capitalisation of ₹ 186 Cr as on 08-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Oxygenta Pharmaceutical Ltd?
Before investing in Oxygenta Pharmaceutical Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.